<table>
<thead>
<tr>
<th>報告人姓名</th>
<th>關係</th>
<th>類型</th>
<th>金額</th>
<th>SEC 文件</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rosen Terry J</td>
<td>首席執行官，10% 股東</td>
<td>賣出</td>
<td>$1,203,959</td>
<td>Form 4</td>
</tr>
<tr>
<td>Jaen Juan C.</td>
<td>總裁，10% 股東</td>
<td>賣出</td>
<td>$466,869</td>
<td>Form 4</td>
</tr>
<tr>
<td>Goeltz Ii Robert C.</td>
<td>首席財務官，10% 股東</td>
<td>賣出</td>
<td>$278,739</td>
<td>Form 4</td>
</tr>
<tr>
<td>Jarrett Jennifer</td>
<td>首席運營官，10% 股東</td>
<td>賣出</td>
<td>$466,869</td>
<td>Form 4</td>
</tr>
<tr>
<td>Azoy Alexander</td>
<td>首席會計官，10% 股東</td>
<td>賣出</td>
<td>$195,433</td>
<td>Form 4</td>
</tr>
<tr>
<td>Tang Carolyn C.</td>
<td>總法律顧問，10% 股東</td>
<td>賣出</td>
<td>$318,496</td>
<td>Form 4</td>
</tr>
<tr>
<td>Markus Richard</td>
<td>首席醫療官，10% 股東</td>
<td>賣出</td>
<td>$210,144</td>
<td>Form 4</td>
</tr>
</tbody>
</table>
<p>包括首席執行官、總裁、首席財務官、首席運營官、首席會計官、總法律顧問和首席醫療官在內的多位 Arcus Biosciences 高管，已出售公司普通股以支付與限制性股票單位（RSUs）歸屬相關的税款扣繳義務。</p>
<p>首席執行官 Terry J Rosen 以加權平均價格 $21.8843 和 $22.1595 賣出 54,691 股，總計 $1,203,959。Rosen 目前直接持有 2,194,809 股。</p>
<p>總裁 Juan C. Jaen 以加權平均價格 $21.8843 和 $22.1595 賣出 21,208 股，總計 $466,869。Jaen 直接持有 346,012 股，並通過信託間接持有 954,063 股。</p>
<p>首席財務官 Goeltz II Robert C. 以加權平均價格 $21.8843 和 $22.1595 賣出 12,662 股，總計 $278,739。Goeltz 直接持有 74,476 股。</p>
<p>首席運營官 Jennifer Jarrett 以加權平均價格 $21.8843 和 $22.1595 賣出 21,208 股，總計 $466,869。Jarrett 直接持有 193,024 股。</p>
<p>首席會計官 Azoy Alexander 以 $21.42 至 $22.59 的價格賣出 8,832 股，總計 $195,433。Alexander 直接持有 18,531 股。</p>
<p>總法律顧問 Carolyn C. Tang 以加權平均價格 $21.8843 和 $22.1595 賣出 14,468 股，總計 $318,496。Tang 直接持有 124,734 股。</p>
<p>首席醫療官 Markus Richard 以加權平均價格 $21.8843 和 $22.1595 賣出 9,546 股，總計 $210,144。Richard 直接持有 65,647 股。</p>

RCUS

<p>Arcus Biosciences 的高管，包括首席執行官、總裁、首席財務官、首席運營官、首席會計官、總法律顧問和首席醫學官，出售了股票以支付 RSU 解禁所產生的税務義務。首席執行官 Terry J Rosen 出售了價值 1,203,959 美元的股票，而其他高管則出售了不同金額的股票。這些交易已在 Form 4 文件中報告</p>

<table>
<thead>
<tr>
<th>Reporter Name</th>
<th>Relationship</th>
<th>Type</th>
<th>Amount</th>
<th>SEC Filing</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rosen Terry J</td>
<td>Chief Executive Officer, 10% Owner</td>
<td>Sell</td>
<td>$1,203,959</td>
<td>Form 4</td>
</tr>
<tr>
<td>Jaen Juan C.</td>
<td>President, 10% Owner</td>
<td>Sell</td>
<td>$466,869</td>
<td>Form 4</td>
</tr>
<tr>
<td>Goeltz Ii Robert C.</td>
<td>Chief Financial Officer, 10% Owner</td>
<td>Sell</td>
<td>$278,739</td>
<td>Form 4</td>
</tr>
<tr>
<td>Jarrett Jennifer</td>
<td>Chief Operating Officer, 10% Owner</td>
<td>Sell</td>
<td>$466,869</td>
<td>Form 4</td>
</tr>
<tr>
<td>Azoy Alexander</td>
<td>Chief Accounting Officer, 10% Owner</td>
<td>Sell</td>
<td>$195,433</td>
<td>Form 4</td>
</tr>
<tr>
<td>Tang Carolyn C.</td>
<td>General Counsel, 10% Owner</td>
<td>Sell</td>
<td>$318,496</td>
<td>Form 4</td>
</tr>
<tr>
<td>Markus Richard</td>
<td>Chief Medical Officer, 10% Owner</td>
<td>Sell</td>
<td>$210,144</td>
<td>Form 4</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>報告人姓名</th>
<th>關係</th>
<th>類型</th>
<th>金額</th>
<th>SEC 文件</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rosen Terry J</td>
<td>首席執行官，10% 股東</td>
<td>賣出</td>
<td>$1,203,959</td>
<td>Form 4</td>
</tr>
<tr>
<td>Jaen Juan C.</td>
<td>總裁，10% 股東</td>
<td>賣出</td>
<td>$466,869</td>
<td>Form 4</td>
</tr>
<tr>
<td>Goeltz Ii Robert C.</td>
<td>首席財務官，10% 股東</td>
<td>賣出</td>
<td>$278,739</td>
<td>Form 4</td>
</tr>
<tr>
<td>Jarrett Jennifer</td>
<td>首席運營官，10% 股東</td>
<td>賣出</td>
<td>$466,869</td>
<td>Form 4</td>
</tr>
<tr>
<td>Azoy Alexander</td>
<td>首席會計官，10% 股東</td>
<td>賣出</td>
<td>$195,433</td>
<td>Form 4</td>
</tr>
<tr>
<td>Tang Carolyn C.</td>
<td>總法律顧問，10% 股東</td>
<td>賣出</td>
<td>$318,496</td>
<td>Form 4</td>
</tr>
<tr>
<td>Markus Richard</td>
<td>首席醫療官，10% 股東</td>
<td>賣出</td>
<td>$210,144</td>
<td>Form 4</td>
</tr>
</tbody>
</table>
</div><p>Several executives at Arcus Biosciences, including the CEO, President, CFO, COO, Chief Accounting Officer, General Counsel, and Chief Medical Officer, have sold shares of the company's common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).</p>
<div class="lb-trans"><p>包括首席執行官、總裁、首席財務官、首席運營官、首席會計官、總法律顧問和首席醫療官在內的多位 Arcus Biosciences 高管，已出售公司普通股以支付與限制性股票單位（RSUs）歸屬相關的税款扣繳義務。</p>
</div><p>Terry J Rosen, CEO, sold 54,691 shares at weighted average prices of $21.8843 and $22.1595, totaling $1,203,959. Rosen now directly owns 2,194,809 shares.</p>
<div class="lb-trans"><p>首席執行官 Terry J Rosen 以加權平均價格 $21.8843 和 $22.1595 賣出 54,691 股，總計 $1,203,959。Rosen 目前直接持有 2,194,809 股。</p>
</div><p>Juan C. Jaen, President, sold 21,208 shares at weighted average prices of $21.8843 and $22.1595, totaling $466,869. Jaen directly owns 346,012 shares and indirectly owns 954,063 shares through a trust.</p>
<div class="lb-trans"><p>總裁 Juan C. Jaen 以加權平均價格 $21.8843 和 $22.1595 賣出 21,208 股，總計 $466,869。Jaen 直接持有 346,012 股，並通過信託間接持有 954,063 股。</p>
</div><p>Goeltz II Robert C., CFO, sold 12,662 shares at weighted average prices of $21.8843 and $22.1595, totaling $278,739. Goeltz directly owns 74,476 shares.</p>
<div class="lb-trans"><p>首席財務官 Goeltz II Robert C. 以加權平均價格 $21.8843 和 $22.1595 賣出 12,662 股，總計 $278,739。Goeltz 直接持有 74,476 股。</p>
</div><p>Jennifer Jarrett, COO, sold 21,208 shares at weighted average prices of $21.8843 and $22.1595, totaling $466,869. Jarrett directly owns 193,024 shares.</p>
<div class="lb-trans"><p>首席運營官 Jennifer Jarrett 以加權平均價格 $21.8843 和 $22.1595 賣出 21,208 股，總計 $466,869。Jarrett 直接持有 193,024 股。</p>
</div><p>Azoy Alexander, Chief Accounting Officer, sold 8,832 shares at prices ranging from $21.42 to $22.59, totaling $195,433. Alexander directly owns 18,531 shares.</p>
<div class="lb-trans"><p>首席會計官 Azoy Alexander 以 $21.42 至 $22.59 的價格賣出 8,832 股，總計 $195,433。Alexander 直接持有 18,531 股。</p>
</div><p>Carolyn C. Tang, General Counsel, sold 14,468 shares at weighted average prices of $21.8843 and $22.1595, totaling $318,496. Tang directly owns 124,734 shares.</p>
<div class="lb-trans"><p>總法律顧問 Carolyn C. Tang 以加權平均價格 $21.8843 和 $22.1595 賣出 14,468 股，總計 $318,496。Tang 直接持有 124,734 股。</p>
</div><p>Markus Richard, Chief Medical Officer, sold 9,546 shares at weighted average prices of $21.8843 and $22.1595, totaling $210,144. Richard directly owns 65,647 shares.</p>
<div class="lb-trans"><p>首席醫療官 Markus Richard 以加權平均價格 $21.8843 和 $22.1595 賣出 9,546 股，總計 $210,144。Richard 直接持有 65,647 股。</p>
</div>

Arcus Biosciences 的高管出售股票以履行税務義務